Cell MedX Corp Top Management
| CMXCDelisted Stock | USD 0.48 0.16 50.00% |
Cell MedX employs about 11 people. The company is managed by 5 executives with a total tenure of roughly 9 years, averaging almost 1.0 years of service per executive, having 2.2 employees per reported executive. Evaluation of Cell MedX's management performance can provide insight into the firm performance.
| BASc ICDD Insider MD Director |
| CPA CMA Insider Treasurer, CFO |
Cell |
Cell MedX Management Team Effectiveness
The company has return on total asset (ROA) of (5.6195) % which means that it has lost $5.6195 on every $100 spent on assets. This is way below average. Cell MedX's management efficiency ratios could be used to measure how well Cell MedX manages its routine affairs as well as how well it operates its assets and liabilities.Cell MedX Workforce Comparison
Cell MedX Corp is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,383. Cell MedX adds roughly 11.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Cell MedX Notable Stakeholders
A Cell MedX stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cell MedX often face trade-offs trying to please all of them. Cell MedX's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cell MedX's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Bradley Hargreaves | VP of Technology and Operations | Profile | |
| BASc ICDD | MD Director | Profile | |
| CPA CMA | Treasurer, CFO | Profile | |
| Joao Costa | COO Director | Profile | |
| Dwayne Yaretz | CEO Director | Profile |
About Cell MedX Management Performance
The success or failure of an entity such as Cell MedX Corp often depends on how effective the management is. Cell MedX management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cell management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cell management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinsons disease, high blood pressure, neuropathy, and kidney functions. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada. CELL MEDX operates under Medical Devices classification in the United States and is traded on OTC Exchange.
The data published in Cell MedX's official financial statements typically reflect Cell MedX's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Cell MedX's quantitative information. For example, before you start analyzing numbers published by Cell accountants, it's essential to understand Cell MedX's liquidity, profitability, and earnings quality within the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Cell MedX's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cell MedX's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cell MedX's management manipulating its earnings.
Cell MedX Workforce Analysis
Traditionally, organizations such as Cell MedX use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cell MedX within its industry.Cell MedX Manpower Efficiency
Return on Cell MedX Manpower
| Revenue Per Employee | 615 | |
| Revenue Per Executive | 1.4K | |
| Net Loss Per Employee | 82.8K | |
| Net Loss Per Executive | 182.2K | |
| Working Capital Per Employee | 3.7K | |
| Working Capital Per Executive | 8K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Cell OTC Stock
If you are still planning to invest in Cell MedX Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cell MedX's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |